奧孟亞股份有限公司口服胜肽
領導者

Anya is a young, agile and innovative publicly listed (TWO: 7776) pharmaceutical company founded in Taipei, Taiwan with offices in India and the United States. Our core mission is to be the authority in oral delivery of peptides. Our patented technology platform Mira/Je® is a flexible solution easy to adapt to a large variety of peptides. Mira/Je® has shown delivery of therapeutic amount in a number of clinical and preclinical studies in a variety of peptides such as teriparatide, leuprorelin, octreotide, semaglutide, liraglutide, tirzepatide and insulin glargine.

奧孟亞管理團隊擁有20年的生物製劑和小分子藥物開發的豐富商業化經驗。

奧孟亞公司的創始理念為是3E: 卓越，參與和效率